Themis Medicare logo

Themis Medicare

THEMISMED NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹1,173 Cr
Volatility
Moderate
P/E Ratio
29.48
EBITDA
₹-0.47 Cr
Return on Equity
7.41%
Debt to Equity
0.25
Book Value
₹39.7
EPS
₹5.43
52W High
₹148
52W Low
₹64.95

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Company has been maintaining a healthy dividend payout of 143%

Weaknesses

6
  • Stock is trading at 2.96 times its book value
  • Company has low interest coverage ratio.
  • The company has delivered a poor sales growth of 8.21% over past five years.
  • Company has a low return on equity of 6.41% over last 3 years.
  • Promoters have pledged 43.4% of their holding.
  • Company has high debtors of 190 days.

Growth Rate

Revenue Growth
-16.57% lower than 3Y
Net Income Growth
-93.52% lower than 3Y
Cash Flow Change
57.13% lower than 3Y
ROE
-35.68% lower than 3Y
ROCE
-24.52% higher than 3Y
EBITDA Margin (Avg.)
-101% level than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
97
105
83
98
123
117
94
72
98
78
90
77
87
Expenses
75
92
74
89
94
100
88
79
108
81
80
73
139
Operating Profit
22
12
8
9
29
17
6
-8
-10
-3
10
4
-52
OPM %
22%
12%
10%
10%
24%
15%
6%
-11%
-10%
-4%
11%
4.9%
-60%
Other Income
6
7
6
5
7
6
1
2
1
5
6
11
97
Interest
2
2
3
2
2
2
3
2
2
3
3
3
3
Depreciation
3
3
3
3
2
2
3
3
3
3
3
3
3
PBT
23
14
8
9
31
18
2
-11
-14
-3
10
9
39
Tax %
19%
19%
10%
24%
21%
20%
69%
-13%
1%
5%
3%
2%
36%
Net Profit
18
11
7
7
25
14
1
-10
-14
-4
10
9
25
EPS in Rs
1.98
1.23
0.8
0.72
2.68
1.55
0.06
-1.05
-1.54
-0.39
1.1
0.97
2.67
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
202
232
217
210
184
202
231
395
354
382
406
342
332
Expenses
184
194
184
184
181
166
181
299
287
330
356
342
374
Operating Profit
18
38
33
25
2
36
49
96
67
52
49
0
-42
OPM %
9%
16%
15%
12%
1.2%
18%
21%
24%
19%
13%
12%
0.1%
-13%
Other Income
13
3
4
6
5
12
13
18
25
24
11
23
118
Interest
15
12
12
12
12
13
13
9
10
9
10
11
11
Depreciation
11
12
7
7
8
8
9
9
10
12
10
10
10
PBT
5
17
18
11
-13
27
41
95
73
53
40
2
55
Tax %
-20%
11%
9%
1%
-15%
8%
14%
23%
22%
19%
25%
40%
—
Net Profit
6
16
16
11
-11
25
36
73
57
44
30
1
40
EPS in Rs
0.73
1.91
1.77
1.23
-1.17
2.7
3.88
7.92
6.18
4.73
3.24
0.12
4.35
Div. Payout %
25%
9%
0%
0%
0%
6%
11%
6%
8%
11%
15%
404%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
8
9
9
9
9
9
9
9
9
9
9
9
Reserves
51
66
143
160
149
174
209
278
330
368
393
389
Borrowings
140
128
82
80
82
100
87
80
92
96
83
100
Other Liabilities
77
73
54
56
74
67
65
61
82
93
102
99
Total Liabilities
277
275
289
305
314
350
371
428
514
566
588
598
Fixed Assets
122
117
124
126
123
116
133
144
162
168
172
167
CWIP
4
6
9
2
2
8
2
3
3
3
3
2
Investments
5
6
23
24
27
35
45
56
70
89
95
109
Other Assets
146
146
133
153
162
191
191
225
279
307
318
320
Total Assets
277
275
289
305
314
350
371
428
514
566
588
598
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
19
26
-2
8
11
0
57
34
16
22
35
-3
Investing
-6
-7
-4
0
-4
-5
-16
-16
-24
-16
-12
-3
Financing
-18
-13
5
-9
-10
7
-26
-18
0
-9
-26
4
Net Cash Flow
-5
5
0
-1
-3
2
16
1
-8
-3
-3
-2
Free Cash Flow
13
18
-7
5
5
-5
39
15
-13
4
21
-8
CFO/OP
101
73
-5
29
490
2
115
55
48
60
93
782
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
82
75
81
120
145
186
123
93
149
170
159
190
Inventory Days
246
243
250
253
287
315
272
150
213
188
233
229
Days Payable
237
145
163
156
187
171
143
79
123
126
142
143
Cash Conversion Cycle
91
172
168
216
244
330
251
164
239
232
250
275
Working Capital Days
-20
-17
-16
19
-1
37
51
72
110
114
121
138
ROCE %
9%
15%
13%
10%
-1%
15%
18%
30%
20%
14%
10%
3%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Themis Medicare insights

51 extracted metrics + investor summaries across FY15–FY26.

Log in — free

Shareholding Pattern

DIIs0.01%Promot.67.11%FIIs0.01%Others9.30%Public23.57%As ofJun 2026
43.39% of promoter holding pledged as of Jun 2026

Documents

1
Concall - May 2026 May 2026
2
Concall - May 2026 May 2026
3
Concall - Feb 2026 Feb 2026
4
Concall - Nov 2025 Nov 2025
5
Concall - Aug 2025 Aug 2025

Frequently Asked Questions about Themis Medicare

What does Themis Medicare Ltd do?
Incorporated in 1969, Themis Medicare manufactures Formulation and API pharmaceutical products[1]
Where is Themis Medicare Ltd (THEMISMED) listed?
Themis Medicare Ltd trades as THEMISMED on the NSE and under code 530199 on the BSE.
Which sector does Themis Medicare Ltd belong to?
Themis Medicare Ltd is classified under the Healthcare sector, in the Pharmaceuticals & Biotechnology industry.
What is the market capitalisation of Themis Medicare Ltd?
Themis Medicare Ltd has a market capitalisation of ₹1,173 Cr, which places it in the Small Cap band.
What is the PE ratio of Themis Medicare Ltd?
Themis Medicare Ltd trades at a PE ratio of 29.48, on earnings per share of ₹5.43, against a book value of ₹39.7 per share.
What is the 52-week high and low of Themis Medicare Ltd?
Over the last 52 weeks Themis Medicare Ltd has traded between ₹64.95 and ₹148.
Does Themis Medicare Ltd pay dividends?
Themis Medicare Ltd has a dividend yield of 0.38%.
What is the Return on Equity (ROE) of Themis Medicare Ltd?
Themis Medicare Ltd reported a return on equity of 7.41%. Its debt-to-equity ratio is 0.25.

Company Information

Incorporated in 1969, Themis Medicare manufactures Formulation and API pharmaceutical products[1]

Website themismedicare.com
CEO Dr. Dinesh Shantilal Patel CChem., FRSC(Lond.), Ph.D.
Employees 1,702
Listed 2007-04-02
Face Value ₹ 1
Issued Size 9,21,00,120

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/THEMISMED.md for Themis Medicare Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List